1Wu Kl,Jiang Gl,Liao Y,et al.A phase I study of gemicitabine with con-current radiotherapy in stageⅢ,locally advanced non-small cell lungcancer[J].Clin Cancer Res,2003;9(7):2472.
2Mambrini A, Fiorentini G, Zamagni D, et al. Intra-arteriaI chemio- therapy for invasive bladder cancer [ J]. J Experimenta Clin Can Res,2009,14(24) :1098 - 1099.
3Dozic J,Bogdarovic J. Curren diagnostic and therapentic approaches to invasinve bladder cancer [ J ]. Medicinski Pregled, 2010, 12 (10) :912 -913.
4Shapiro O,Jones K,Wang C,et al. Risk of post-operative intravesi- cal mitomycin C instillation following transurethral bladder tumor re- section[J]. CanadJUrol,2010,12(29):1076-1077.
5Yoneyama T, Tobisawa Y, Yoneyama T, et al. Carboplatin - based combination chemotherapy for elderly patients with advanced blad- der cancer[J]. Int J Clin Oncol,2015,20(2) :369 - 374.
6Yasuda Y, Tobino K, Ko Y, et al. Successful treatment with car- boplatin and pemetrexed for multiple lymph node metastases of lymphoepithelioma- like carcinoma from an unknown primary site[J]. Intern Med,2015,54(20):2 651 -2 654.
7Petrioli R, Roviello G, Fiaschi AI, et al. Carboplatin, methotrex- ate, vinblastine, and epirubicin (M - VECa) as salvage treatment in patients with advanced bladder cancer: a phase I] study[J]. Anticancer Drugs,2015,26(8) :878 - 883.
8Koie T, Ohyama C, Yamamoto H, et al. Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associ- ated with a survival benefit in patients with clinical T2 bladder cancer[J]. Med Oncol, 2014,31 (5) : 949 - 953.
